Phibro Animal Health (PAHC) Gross Profit (2012 - 2026)

Phibro Animal Health's Gross Profit history runs 15 years deep, the most recent figure standing at $125.7 million for Q1 2026.

• On a quarterly basis, Gross Profit rose 20.18% year-over-year to $125.7 million in Q1 2026; TTM through Mar 2026 was $488.1 million, a 29.45% increase from a year earlier, with the FY2025 full-year figure at $399.9 million, up 27.74% from the prior year.
• Gross Profit declined to $125.7 million in Q1 2026 per PAHC's latest filing, from $132.7 million in the prior quarter.
• Across five years, Gross Profit topped out at $132.7 million in Q4 2025 and bottomed at $67.7 million in Q3 2023.
• The 5-year median for Gross Profit is $79.6 million (2024), against an average of $90.6 million.
• Across the five-year window, Gross Profit decreased 2.24% in 2023 and jumped 43.46% in 2025, its largest moves.
• Year by year, Gross Profit stood at $77.4 million in 2022, then grew by 1.59% to $78.6 million in 2023, then increased by 29.58% to $101.9 million in 2024, then surged by 30.22% to $132.7 million in 2025, then slipped by 5.26% to $125.7 million in 2026.
• Per Business Quant, the three latest PAHC Gross Profit figures stand at $125.7 million (Q1 2026), $132.7 million (Q4 2025), and $119.8 million (Q3 2025).